Rodriguez said last week that he’d rejoin the Yankees today for the start of a four-game series in Texas against the Rangers. Rodriguez hasn’t played in Major League Baseball this season while recovering from left hip surgery in January and had a scan on his thigh yesterday after experiencing tightness during a July 20 minor-league rehabilitation game.
Rodriguez, who turns 38 on July 27, said in a statement that he’s “extremely disappointed with the results of the MRI” and hopes to return as soon as possible. The Yankees said in a news release that Rodriguez will return to Tampa, Florida, for rest and treatment.
Rodriguez will remain on the disabled list, though he can no longer play in official minor league games because the 20-day window for his rehab stint expired, the team said.
The Yankees, who have also had Mark Teixeira, Derek Jeter and Curtis Granderson experience setbacks in their return from injuries, said they may petition MLB for an additional rehab assignment for Rodriguez.
A 14-time All-Star and three-time American League Most Valuable Player, Rodriguez hasn’t played in the majors since last season’s playoffs, when he batted .120, with three hits and 12 strikeouts in 25 at-bats. He was benched at times during the postseason, and had surgery in January on his torn labrum.
The Miami New Times reported that month that Rodriguez’s name was included on a client list at the Biogenesis of America LLC clinic in Coral Gables, Florida, which was selling performance-enhancing drugs. ESPN reported in February that Biogenesis founder Anthony Bosch injected Rodriguez with banned substances, and the network said earlier this month that MLB commissioner Bud Selig would seek to suspend as many as 22 players without pay for their relationship with Biogenesis.
Rodriguez, who is fifth on baseball’s career list with 647 home runs, has said he wasn’t a patient of Bosch and declined to comment on the issue.
To contact the reporter on this story: Erik Matuszewski in New York at firstname.lastname@example.org
To contact the editor responsible for this story: Michael Sillup at email@example.com